Published in Lab Law Weekly, August 17th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Nabi Biopharmaceuticals.
Report 1: Nabi Biopharmaceuticals (NASDAQ:NABI) announced that it has created the Nabi Biologics strategic business unit (SBU) and expanded the role of Dr. Raafat Fahim, Senior Vice President, Research, Technical and Production Operations, to include the new position of Chief Operating Officer and General Manager of the Biologics SBU. Nabi Biologics is responsible for advancing the company's protein and immunological products and development pipeline, including Nabi-...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.